Maria Rosaria Raspollini
University of Florence, Azienda Ospedaliero-Universitaria Careggi
Papers
6
Total Citations
119
H-Index
5
About
Maria Rosaria Raspollini is a leading pathologist whose work sits at the critical intersection of urologic oncology and robotic surgery. Her primary research focuses on the histopathological characterization of renal cell carcinoma (RCC), particularly the tumor-parenchyma interface, and its implications for oncologic outcomes after robot-assisted tumor enucleation. She has made seminal contributions to understanding how detailed pathological analysis can validate and refine surgical techniques, demonstrating that robotic enucleation is both safe and effective for elective RCC treatment. Her landmark 2018 study, cited over 50 times, provided the first long-term evidence linking tumor-parenchyma interface analysis to favorable oncologic outcomes. Beyond renal cancer, she has explored computer-aided diagnosis in prostate cancer and innovative robotic approaches for rare tumors like adult Wilms’ tumor and seminal vesicle cystadenoma. Her work consistently bridges surgical innovation with rigorous pathological validation, making her a key figure in evidence-based urologic oncology. With papers spanning from 2015 to 2025, her research continues to shape clinical practice, particularly for complex cases such as single-kidney patients undergoing partial nephrectomy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6